XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Reporting - Reconciliation of Segment Profits to Income before Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Profits $ 3,650,000 $ 4,861,000
Interest income 112,000 7,000
Interest expense (242,000) (243,000)
Amortization (543,000) (699,000)
Depreciation (448,000) (421,000)
Research and development (4,276,000) (2,576,000)
Restructuring costs (67,000) (53,000)
Operating Segments    
Segment Reporting Information [Line Items]    
Profits 9,706,000 10,086,000
Operating Segments | Pharmaceutical segment    
Segment Reporting Information [Line Items]    
Profits 9,140,000 9,501,000
Operating Segments | Animal Health segment    
Segment Reporting Information [Line Items]    
Profits 566,000 585,000
Corporate, Non-Segment    
Segment Reporting Information [Line Items]    
Profits 164,000 194,000
Segment Reconciling Items    
Segment Reporting Information [Line Items]    
Interest income 112,000 7,000
Interest expense (242,000) (243,000)
Amortization (543,000) (699,000)
Depreciation (398,000) (378,000)
Research and development (4,147,000) (2,446,000)
Restructuring costs (67,000) (53,000)
Charge for Zetia antitrust litigation settlements (573,000) 0
Other unallocated, net $ (362,000) $ (1,607,000)